No Data
No Data
No Data
No Data
No Data
CVAC, SBNY and CRMD Are Among After Hour Movers
Seeking AlphaApr 18 05:01
Analysts Just Made A Massive Upgrade To Their Sutro Biopharma, Inc. (NASDAQ:STRO) Forecasts
Sutro Biopharma, Inc. (NASDAQ:STRO) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts greatly increased t
Simply Wall StApr 5 19:21
Piper Sandler Trims Price Target on Sutro Biopharma to $11 From $12, Maintains Overweight Rating
Sutro Biopharma (STRO) has an average buy rating and price target range of $8 to $20, according to analysts polled by Capital IQ. Price: 5.11, Change: +0.01, Percent Change: +0.29
MT NewswiresApr 4 00:00
Sutro Biopharma Is Maintained at Outperform by Oppenheimer
Sutro Biopharma Is Maintained at Outperform by Oppenheimer
Dow JonesApr 3 22:16
Truist Securities Maintains Buy on Sutro Biopharma, Lowers Price Target to $18
Truist Securities analyst Asthika Goonewardene maintains Sutro Biopharma with a Buy and lowers the price target from $25 to $18.
Analyst UpgradesApr 3 21:32
Sutro Biopharma Price Target Maintained With a $17.00/Share by JMP Securities
Sutro Biopharma Price Target Maintained With a $17.00/Share by JMP Securities
Dow JonesApr 3 20:34
No Data
No Data